Back

Discordant severity grading in right ventricular dysfunction: prognostic implications of conventional parameters versus 3D echocardiography-derived ejection fraction

12 December 2025 (15:30 - 16:15)
Organised by: Logo
Congress Presentation Part of: The third dimension of echo Systolic and Diastolic Function EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Mate Tolvaj

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

5 More presentations in this session

Presentation thumbnail
3-dimensional transthoracic and transesophageal echocardiography characterization of the right atrial appendage according to AF pattern.
Doctor L. Soulat-Dufour (Paris, FR)
Abstract Slides
Presentation thumbnail
3D echocardiography derived cardiac power output as an independent prognostic marker for heart failure in young patients with STEMI
Doctor A. Scarlatescu (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Shaping insights: 3D echocardiography-derived right ventricular global shape analysis in secondary tricuspid regurgitation subtypes
Doctor A. Ferencz (Budapest, HU)
Abstract Slides
Presentation thumbnail
Prognostic significance of ventricular stiffness assessed by 3D echocardiography: introducing a novel biventricular stiffness index
Doctor A. Vijiiac (Bucharest, RO)
Abstract Slides
Presentation thumbnail
3D ventricular stiffness versus systolic dysfunction: rethinking outcome predictors in dilated cardiomyopathy
Doctor A. Vijiiac (Bucharest, RO)
Abstract Slides

Access the full session

Session thumbnail
The third dimension of echo

The Event

Event poster

EACVI 2025

12 December 2025 15:30 CET
You may be interested in
thumbnail
Congress Session
Recent advances in clinical practice guidelines: what the imager needs to know and apply - Part 2
thumbnail
Congress Presentation
Diastolic function and left atrial pressures
thumbnail
Congress Presentation
Threshold values for diastolic dysfunction parameters indicative of increased mortality risk in a real-world patient cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources